Company: INKT
Filing Date: 2025-08-14
Form Type: 8-K
Source: 0001171843-25-005405
Chunk: 0

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-08-14
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial Condition.

On August 14, 2025, MiNK Therapeutics, Inc. announced its financial results for the quarter ended June 30, 2025. In connection with the announcement, the Company issued a press release, which is being furnished as Exhibit 99.1 to this current report on Form 8-K.

The information set forth under Item 2.02 and in Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibit

The following exhibit is furnished herewith:

  99.1      Press Release dated August 14, 2025                                          
 ─────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)